- Home
- JWEL vs PBM Comparison
JWEL vs PBM Comparison
Compare JWEL & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWEL
- PBM
- Stock Information
- Founded
- JWEL 2012
- PBM 1994
- Country
- JWEL China
- PBM Canada
- Employees
- JWEL N/A
- PBM N/A
- Industry
- JWEL Other Consumer Services
- PBM
- Sector
- JWEL Consumer Discretionary
- PBM
- Exchange
- JWEL Nasdaq
- PBM NYSE
- Market Cap
- JWEL 4.1M
- PBM 4.0M
- IPO Year
- JWEL 2021
- PBM N/A
- Fundamental
- Price
- JWEL $1.95
- PBM $0.05
- Analyst Decision
- JWEL
- PBM
- Analyst Count
- JWEL 0
- PBM 0
- Target Price
- JWEL N/A
- PBM N/A
- AVG Volume (30 Days)
- JWEL 16.1K
- PBM 8.8M
- Earning Date
- JWEL 11-29-2024
- PBM 11-29-2024
- Dividend Yield
- JWEL N/A
- PBM N/A
- EPS Growth
- JWEL N/A
- PBM N/A
- EPS
- JWEL N/A
- PBM N/A
- Revenue
- JWEL $160,009,293.00
- PBM N/A
- Revenue This Year
- JWEL N/A
- PBM N/A
- Revenue Next Year
- JWEL N/A
- PBM N/A
- P/E Ratio
- JWEL N/A
- PBM N/A
- Revenue Growth
- JWEL N/A
- PBM N/A
- 52 Week Low
- JWEL $1.00
- PBM $0.05
- 52 Week High
- JWEL $3.14
- PBM $14.55
- Technical
- Relative Strength Index (RSI)
- JWEL 54.81
- PBM 27.59
- Support Level
- JWEL $1.81
- PBM $0.06
- Resistance Level
- JWEL $2.15
- PBM $0.06
- Average True Range (ATR)
- JWEL 0.18
- PBM 0.01
- MACD
- JWEL 0.01
- PBM 0.00
- Stochastic Oscillator
- JWEL 49.09
- PBM 1.07
About JWEL Jowell Global Ltd.
Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.